(firstQuint)S-CEI of Nexium in Paediatric Patients.

 The objective of this investigation is to capture the followings when Nexium capsules or Nexium granules for suspension (single-dose package) are administered to pediatric patients in clinical practice after launch.

 1.

 Development of adverse reactions which are unexpected from Precaution for Use 2.

 Development of adverse reactions 3.

 Efficacy.

 S-CEI of Nexium in Paediatric Patients@highlight

To capture safety and efficacy when Nexium are administered to pediatric patients in clinical practice after launch